| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |